Novavax
NVAX
#5753
Rank
โ‚ฌ0.96 B
Marketcap
5,93ย โ‚ฌ
Share price
0.73%
Change (1 day)
-30.95%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ1.01 Billion

According to Novavax's latest financial reports the company's total assets are โ‚ฌ1.01 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.49 B-7.78%
2023-12-31โ‚ฌ1.62 B-22.78%
2022-12-31โ‚ฌ2.10 B-7.45%
2021-12-31โ‚ฌ2.27 B76.85%
2020-12-31โ‚ฌ1.28 B733.31%
2019-12-31โ‚ฌ0.15 B-15.07%
2018-12-31โ‚ฌ0.18 B-27.89%
2017-12-31โ‚ฌ0.25 B-32.75%
2016-12-31โ‚ฌ0.37 B6.17%
2015-12-31โ‚ฌ0.35 B55.58%
2014-12-31โ‚ฌ0.22 B33.29%
2013-12-31โ‚ฌ0.17 B120.05%
2012-12-31โ‚ฌ77.37 M50.92%
2011-12-31โ‚ฌ51.26 M-8.89%
2010-12-31โ‚ฌ56.26 M-5.83%
2009-12-31โ‚ฌ59.75 M9.01%
2008-12-31โ‚ฌ54.81 M-12.34%
2007-12-31โ‚ฌ62.52 M-32.31%
2006-12-31โ‚ฌ92.36 M29.67%
2005-12-31โ‚ฌ71.23 M23.89%
2004-12-31โ‚ฌ57.49 M-13.99%
2003-12-31โ‚ฌ66.84 M21.52%
2002-12-31โ‚ฌ55.01 M-27.61%
2001-12-31โ‚ฌ75.99 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
โ‚ฌ0.20 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.99 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ1.25 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.38 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ98.18 B 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ179.04 B 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ92.03 B 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚ฌ7.56 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.73 B 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ0.55 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA